Advertisement
Advertisement

ASTH

ASTH logo

Astrana Health Inc. Common Stock

39.30
USD
Sponsored
+3.22
+8.92%
May 08, 16:00 UTC -4
Closed
exchange

Pre-Market

37.90

-1.40
-3.58%

ASTH Earnings Reports

Positive Surprise Ratio

ASTH beat 20 of 32 last estimates.

63%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$992.79M
/
$0.34
Implied change from Q1 26 (Revenue/ EPS)
+2.87%
/
-54.05%
Implied change from Q2 25 (Revenue/ EPS)
+51.62%
/
+78.95%

Astrana Health Inc. Common Stock earnings per share and revenue

On May 07, 2026, ASTH reported earnings of 0.74 USD per share (EPS) for Q1 26, beating the estimate of 0.30 USD, resulting in a 142.70% surprise. Revenue reached 965.10 million, compared to an expected 968.19 million, with a -0.32% difference. The market reacted with a +8.92% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of 0.34 USD, with revenue projected to reach 992.79 million USD, implying an decrease of -54.05% EPS, and increase of 2.87% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Option Care Health, Inc. Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.37
Actual
$0.40
Surprise
+5.46%
logo
LifeStance Health Group, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.04
Surprise
+488.24%
logo
Elanco Animal Health Incorporated Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
$0.35
Actual
$0.40
Surprise
+13.38%
logo
Encompass Health Corporation Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
$1.51
Actual
$1.60
Surprise
+5.83%
logo
DaVita Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$2.34
Actual
$2.87
Surprise
+22.59%
logo
Addus HomeCare Corp.
Report Date
May 04, 2026 For Q1 26
Estimate
$1.58
Actual
$1.62
Surprise
+2.42%
logo
US Physical Therapy Inc
Report Date
May 06, 2026 For Q1 26
Estimate
$0.55
Actual
$0.46
Surprise
-17.25%
logo
The Pennant Group, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
$0.31
Actual
$0.32
Surprise
+2.30%
FAQ
For Q1 2026, Astrana Health Inc. Common Stock reported EPS of $0.74, beating estimates by 142.7%, and revenue of $965.10M, -0.32% below expectations.
The stock price moved up 8.92%, changed from $36.08 before the earnings release to $39.30 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 9 analysts, Astrana Health Inc. Common Stock is expected to report EPS of $0.34 and revenue of $992.79M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement